Global Extracorporeal Membrane Oxygenators (ECMO) Market Size By Type (Infant Paediatric Oxygenators, Adult Oxygenators), By Application (Respiratory, Cardiac), By Region, And Segment Forecasts, 2023...

The Global Extracorporeal Membrane Oxygenators (ECMO) Market was valued at USD 738.2 million in 2023 and is expected to surpass USD 1.46 billion by 2031, expanding at a CAGR of 8.9% during the forecast period from 2023 to 2031. The growing incidence of cardiopulmonary diseases, increasing utilization of ECMO in critical care settings, and technological advancements in ECMO systems are key factors driving the market. ECMO systems provide prolonged cardiac and respiratory support, proving lifesaving in cases of severe heart or lung failure.

Drivers:

1. Rising Prevalence of Cardiopulmonary Diseases:

An increasing number of patients suffering from conditions such as acute respiratory distress syndrome (ARDS), cardiac arrest, and chronic obstructive pulmonary disease (COPD) are fueling the demand for ECMO systems.

2. Expansion of Critical Care Infrastructure:

Hospitals and healthcare institutions worldwide are upgrading their intensive care units (ICUs) to accommodate advanced life-support technologies like ECMO, boosting market demand.

3. Technological Innovations:

Continuous R&D in ECMO technology, including portable systems and automated monitoring tools, has enhanced safety and effectiveness, thereby supporting higher adoption rates.

Restraints:

1. High Cost of ECMO Procedures:

The implementation and maintenance of ECMO are expensive, which limits access, particularly in lower-income and resource-constrained settings.

2. Risk of Complications:

Despite its life-saving potential, ECMO carries risks such as bleeding, infection, and thrombosis, which can deter both clinicians and patients.

Opportunity:

1. Rising Demand in Emerging Economies:

Emerging markets in Asia-Pacific and Latin America are witnessing rising healthcare investments and infrastructure development, presenting untapped opportunities for ECMO adoption.

2. Strategic Collaborations and Clinical Trials:

Collaborative efforts between medical device companies and healthcare institutions to conduct clinical trials and introduce improved ECMO devices are expected to drive innovation and adoption.

Market by System Type Insights:

The market is segmented by system type into Veno-Venous (VV) ECMO and Veno-Arterial (VA) ECMO. In 2023, the Veno-Venous ECMO segment held the largest share due to its growing application in treating severe respiratory failures. However, the Veno-Arterial ECMO segment is projected to grow rapidly owing to increasing cardiac cases and post-cardiotomy support.

Market by End-use Insights:

By end-use, the market is divided into hospitals, ambulatory surgical centers, and specialized cardiac centers. Hospitals dominated the segment in 2023, accounting for over 60% of global revenue, due to the availability of advanced ICUs and skilled medical personnel. Specialized cardiac centers are anticipated to exhibit the highest CAGR during the forecast period.

Market by Regional Insights:

North America led the market in 2023, driven by high healthcare spending, favorable reimbursement policies, and a strong presence of ECMO system manufacturers. Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by the increasing prevalence of cardiac and respiratory conditions and expanding critical care capabilities in countries such as China and India.

Competitive Scenario:

Key market players include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Abbott Laboratories, Xenios AG (Fresenius Medical Care), Eurosets, and Nipro Corporation. Companies are focusing on developing compact, portable ECMO systems and expanding their footprint through acquisitions and partnerships.

Key Developments:

In 2024, Getinge launched its new Rotaflow II ECMO system with enhanced user interface and integrated monitoring.

In 2023, LivaNova announced a partnership with leading cardiac centers across Europe for a multi-center trial to evaluate next-gen ECMO outcomes.

In 2022, Medtronic introduced a modular ECMO device aimed at mobile and emergency critical care applications.

Scope of Work – Global Extracorporeal Membrane Oxygenators (ECMO) Market

Report Metric Details

Market Size (2023) USD 738.2 million

Projected Market Size (2031) USD 1.46 billion

CAGR (2023–2031) 8.9%

Market Segments By System Type (VV ECMO, VA ECMO), End-use, Region

Growth Drivers Rising cardiopulmonary cases, ICU expansions

Opportunities